Latest filing: Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
ObservedCompany dossier
Hester Biosciences
NSE:HESTERBIO · ISIN INE782E01017
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Hester Biosciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹63.2 Cr · PAT ₹11.4 Cr.
Exchange XBRLLatest ownership: promoter group 53.73% and public 46.27% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE · conference call
Observed
Source filing Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recording
BSE · conference call recording
Observed
Source filing Hester Biosciences Ltd - 524669 - Launch Of Interactive Microsite Of 39Th Annual Report FY 2025-26
BSE · annual report
Observed
Source filing General Updates - Hester Biosciences Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹63.2 Cr
- Profit after tax
- ₹11.4 Cr
- EPS
- ₹13.41
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 53.73%
- Public
- 46.27%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL